These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Autonomic nervous system and primary open angle glaucoma--pathogenetic and clinical correlations]. Wierzbowska J; Wierzbowski R; Stankiewicz A; Robaszkiewicz J Klin Oczna; 2009; 111(1-3):75-9. PubMed ID: 19517852 [TBL] [Abstract][Full Text] [Related]
25. Incidence of open-angle glaucoma in central Sweden. Ekström C Acta Ophthalmol; 2008 Nov; 86(7):747-54. PubMed ID: 18785965 [TBL] [Abstract][Full Text] [Related]
26. [Long-term results after selective laser trabeculoplasty -- a clinical study on 269 eyes]. Best UP; Domack H; Schmidt V Klin Monbl Augenheilkd; 2005 Apr; 222(4):326-31. PubMed ID: 15844043 [TBL] [Abstract][Full Text] [Related]
27. Glaucoma. Shah R; Wormald R Clin Evid; 2003 Jun; (9):729-36. PubMed ID: 15366163 [No Abstract] [Full Text] [Related]
28. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients. Chiselită D; Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041 [TBL] [Abstract][Full Text] [Related]
29. Predictors of long-term progression in the early manifest glaucoma trial. Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z; Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686 [TBL] [Abstract][Full Text] [Related]
30. Phacotrabeculectomy in treatment of primary angle-closure glaucoma and primary open-angle glaucoma. Lai JS; Tham CC; Chan JC; Lam DS Jpn J Ophthalmol; 2004; 48(4):408-11. PubMed ID: 15295672 [TBL] [Abstract][Full Text] [Related]
31. [Magnetophores in the treatment of glaucoma]. Krylova LD Vestn Oftalmol; 1982; (5):63-4. PubMed ID: 7147561 [No Abstract] [Full Text] [Related]
32. Open-angle glaucoma: Tips for earlier detection and treatment selection. Aref AA; Schmitt BP J Fam Pract; 2005 Feb; 54(2):117-25. PubMed ID: 15689285 [No Abstract] [Full Text] [Related]
33. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects. Ngan R; Lam DL; Mudumbai RC; Chen PP Am J Ophthalmol; 2007 Aug; 144(2):310-1. PubMed ID: 17659968 [TBL] [Abstract][Full Text] [Related]
34. Lifetime visual prognosis for patients with primary open-angle glaucoma. Ang GS; Eke T Eye (Lond); 2007 May; 21(5):604-8. PubMed ID: 16485015 [TBL] [Abstract][Full Text] [Related]
35. Glaucoma. Shah R; Wormald R Clin Evid; 2005 Jun; (13):797-806. PubMed ID: 16135279 [No Abstract] [Full Text] [Related]
36. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I; Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874 [TBL] [Abstract][Full Text] [Related]
37. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. Shingleton BJ; Pasternack JJ; Hung JW; O'Donoghue MW J Glaucoma; 2006 Dec; 15(6):494-8. PubMed ID: 17106361 [TBL] [Abstract][Full Text] [Related]
38. [Life quality of patients with primary open-angle glaucoma]. Kozina EV Vestn Oftalmol; 2004; 120(5):31-3. PubMed ID: 15529538 [No Abstract] [Full Text] [Related]
39. [The medical treatment of glaucoma]. Sapir-Pichhadze R; Blumenthal E Harefuah; 2003 Jan; 142(1):66-9, 76. PubMed ID: 12647493 [TBL] [Abstract][Full Text] [Related]